EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Treatment of diabetic foot chronic ulcers and neuropathy with placenta-derived stem cells

Michael H Carstens, Arlen Beatriz Ríos, Juan Sevilla, Carlos Rivera, Osman Pravia, Dorian Calero, Samuel Vilchez, Kenneth A Bertram, Anthony Atala

Stem Cells Translational Medicine · 2026-10-16 · 15 (11)

DOI: 10.1093/stcltm/szag085 ↗
AbstractBibliografische Angaben

Abstract

Abstract Aim This first in human study sought to determine the safety and clinical effects of placenta-derived stem cells (PSCs) administered by injection in a dose-escalation trial in diabetic subjects with foot ulceration (DFU) and peripheral neuropathy (DPN). Methods Subjects were enrolled with non-healing wounds of 10-100 cm2 despite standard therapy for ≥3 months. Objectives included safety, wound healing, changes in neuropathy and in ankle/foot vascular flow. Ten patients received PSC implantation to the DFU circumference, into the ulcer bed and along the pedal arteries, with a total dose escalation of 30, 40, and 60 million (M) cells in 4, 3, and 3 subjects, respectively. Results There were no PSC-treatment related serious adverse events. Wound healing was demonstrated in 10/10 subjects at 6 months. DPN improved in all subjects; with 9 of 10 achieving normal protective sensation by 12 months. Conclusions Local implantation of PSCs for DFU and DPN is safe and of potential clinical value.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →